Viking Therapeutics (VKTX) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Jefferies Downgrades Alfen (ALFEN:NA) (ALFNF) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
